外科合伙人 SGRY
$23.20 +$0.03 (+0.13%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $23.20 0.00%
开盘$23.17
昨收$23.17
当日区间$23.17 – $23.23
成交量3.11M
市值$2.99B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$848.90M+2.7% YoY
营业利润$116.50M-4.0% YoY
净利润$29.70M-33.9% YoY
摊薄每股收益-$0.12-500.0% YoY
自由现金流$37.50M-35.2% YoY
经营现金流$59.30M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率22.5%
营业利润率13.7%
净利率-2.6%
净资产收益率-5.2%
资产收益率-1.1%
投入资本回报率2.4%
流动比率1.95
负债/资产比率56.9%
现金及投资$216.70M
总负债$4.02B
净现金（净负债）-$3.80B
自由现金流/营收5.6%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $848.90M | $810.90M | $3.31B | $885.00M | $821.50M |
| 营业总收入 | $848.90M | $810.90M | $3.31B | $885.00M | $821.50M |
| 营业成本 | $658.70M | $650.70M | $2.54B | $672.80M | $626.20M |
| 毛利润 | $190.20M | $160.20M | $765.00M | $212.20M | $195.30M |
| 营业费用 | $73.70M | $76.10M | $294.20M | $87.40M | $60.20M |
| 销售及管理费用 | $36.30M | $39.30M | $118.20M | $23.70M | $22.40M |
| -管理费用 | $36.30M | $39.30M | $118.20M | $23.70M | $22.40M |
| 折旧、摊销与折耗 | $39.30M | $38.50M | $176.00M | $59.90M | $39.50M |
| -折旧与摊销 | $39.30M | $38.50M | $176.00M | $59.90M | $39.50M |
| 其他营业费用 | -$1.90M | -$1.70M | – | – | -$1.70M |
| 营业利润 | $116.50M | $84.10M | $470.80M | $124.80M | $135.10M |
| 非经营性利息净收入（支出） | -$69.80M | -$69.10M | -$272.60M | -$67.60M | -$74.90M |
| 非经营性利息支出 | $69.80M | $69.10M | $272.60M | $67.60M | $74.90M |
| 其他收入（支出） | -$14.40M | -$18.30M | -$81.30M | -$14.60M | -$29.40M |
| 权益法投资收益 | $6.40M | $4.10M | $22.90M | $6.60M | $5.20M |
| 特殊收益（费用） | -$20.80M | -$22.40M | -$112.90M | -$29.90M | -$34.60M |
| -减：重组及并购费用 | $18.40M | $15.60M | $73.90M | $18.50M | $12.60M |
| -业务出售收益 | -$2.40M | -$4.30M | -$30.40M | -$11.40M | -$15.60M |
| 税前利润 | $32.30M | -$3.30M | $116.90M | $42.60M | $30.80M |
| 税费 | $2.60M | -$1.20M | $18.00M | $13.60M | $5.50M |
| 净利润 | $29.70M | -$2.10M | $98.90M | $29.00M | $25.30M |
| 持续经营利润 | $29.70M | -$2.10M | $98.90M | $29.00M | $25.30M |
| 少数股东权益 | $44.70M | $33.80M | $176.80M | $44.00M | $48.00M |
| 归属母公司净利润 | -$15.00M | -$35.90M | -$77.90M | -$15.00M | -$22.70M |
| 归属普通股股东净利润 | -$15.00M | -$35.90M | -$77.90M | -$15.00M | -$22.70M |
| 基本每股收益 | -$0.12 | -$0.28 | -$0.61 | -$0.12 | -$0.18 |
| 摊薄每股收益 | -$0.12 | -$0.28 | -$0.61 | -$0.12 | -$0.18 |
| -减：其他特殊支出 | – | $2.50M | $8.60M | $0.00 | $6.40M |
| 其他非经营性收入（支出） | – | – | $8.70M | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $8.05B | $8.04B | $8.12B | $8.12B | $7.95B |
| 流动资产合计 | $1.13B | $1.08B | $1.15B | $1.15B | $1.10B |
| 现金及现金等价物与短期投资 | $216.70M | $182.30M | $239.90M | $239.90M | $203.40M |
| -现金及现金等价物 | $216.70M | $182.30M | $239.90M | $239.90M | $203.40M |
| 应收款 | $616.60M | $603.40M | $602.20M | $602.20M | $579.30M |
| -应收账款 | $616.60M | $603.40M | $602.20M | $602.20M | $579.30M |
| 预付资产 | $48.30M | – | – | – | – |
| 存货 | $98.80M | $100.50M | $96.60M | $96.60M | $92.30M |
| 其他流动资产 | $145.60M | $196.30M | $212.00M | $212.00M | $227.20M |
| 非流动资产合计 | $6.92B | $6.96B | $6.97B | $6.97B | $6.84B |
| 固定资产净值 | $1.40B | $1.42B | $1.44B | $1.44B | $1.44B |
| -固定资产原值 | $2.12B | $2.10B | $2.09B | $2.09B | $2.06B |
| -累计折旧 | -$718.00M | -$686.00M | -$651.20M | -$651.20M | -$619.70M |
| 投资及预付款 | $226.90M | $225.40M | $234.00M | $234.00M | $229.40M |
| -长期股权投资 | $226.90M | $225.40M | $234.00M | $234.00M | $229.40M |
| 商誉及其他无形资产 | $5.24B | $5.25B | $5.24B | $5.24B | $5.13B |
| 其他非流动资产 | $53.50M | $72.80M | $56.80M | $56.80M | $40.70M |
| 负债合计 | $4.58B | $4.56B | $4.59B | $4.59B | $4.39B |
| 流动负债合计 | $578.50M | $581.70M | $615.50M | $615.50M | $586.00M |
| 应付款 | $227.30M | $214.90M | $255.30M | $255.30M | $217.40M |
| -应付账款 | $175.20M | $168.60M | $208.70M | $208.70M | $174.60M |
| -其他应付款 | $52.10M | $46.30M | $46.60M | $46.60M | $42.80M |
| 一年内应计费用 | $207.70M | $217.00M | $213.50M | $213.50M | $211.00M |
| 短期债务及融资租赁负债 | $143.50M | $142.60M | $142.00M | $142.00M | $144.30M |
| -一年内到期债务 | $102.90M | $100.40M | $99.30M | $99.30M | $103.00M |
| -一年内到期融资租赁负债 | $40.60M | $42.20M | $42.70M | $42.70M | $41.30M |
| 非流动负债合计 | $4.00B | $3.98B | $3.98B | $3.98B | $3.81B |
| 长期债务及融资租赁负债 | $3.91B | $3.89B | $3.88B | $3.88B | $3.73B |
| -长期债务 | $3.65B | $3.61B | $3.60B | $3.60B | $3.46B |
| -长期融资租赁负债 | $266.30M | $271.90M | $279.90M | $279.90M | $266.30M |
| 一年以上递延负债 | $54.40M | $52.10M | $53.40M | $53.40M | $42.60M |
| 其他非流动负债 | $33.80M | $41.60M | $41.20M | $41.20M | $38.10M |
| 股东权益合计 | $3.47B | $3.48B | $3.53B | $3.53B | $3.55B |
| 股东权益 | $1.67B | $1.69B | $1.71B | $1.71B | $1.73B |
| 股本 | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M |
| -普通股 | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.54B | $2.55B | $2.54B | $2.54B | $2.54B |
| 留存收益 | -$866.10M | -$851.10M | -$815.20M | -$815.20M | -$800.20M |
| 不影响留存收益的损益 | -$8.90M | -$10.50M | -$13.80M | -$13.80M | -$14.40M |
| 少数股东权益 | $1.80B | $1.79B | $1.81B | $1.81B | $1.82B |
| 其他流动负债 | – | $7.20M | $4.70M | $4.70M | $13.30M |
| -商誉 | – | – | $5.19B | $5.19B | – |
| -其他无形资产 | – | – | $41.00M | $41.00M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $59.30M | $11.70M | $274.30M | $103.40M | $83.60M |
| 持续经营经营活动现金流净额 | $59.30M | $11.70M | $274.30M | $103.40M | $83.60M |
| 持续经营净利润 | $29.70M | -$2.10M | $98.90M | $29.00M | $25.30M |
| 持续经营损益 | $1.20M | $6.90M | $30.90M | $9.60M | $17.70M |
| 折旧、折耗与摊销 | $39.30M | $38.50M | $176.00M | $59.90M | $39.50M |
| 递延税款 | $2.20M | -$1.30M | $16.70M | $13.40M | $5.10M |
| 其他非现金项目 | $11.30M | $13.50M | $47.40M | $12.10M | $11.80M |
| 营运资金变动 | -$28.20M | -$49.60M | -$110.40M | -$18.40M | -$18.40M |
| -应收款变动 | -$15.00M | $3.60M | -$53.80M | -$46.10M | -$16.20M |
| -其他营运资金变动 | -$13.20M | -$53.20M | -$56.60M | $27.70M | -$2.20M |
| 投资活动现金流净额 | -$19.80M | -$13.40M | -$246.60M | -$126.10M | -$46.20M |
| 持续经营投资活动现金流净额 | -$19.80M | -$13.40M | -$246.60M | -$126.10M | -$46.20M |
| 固定资产购置及出售净额 | -$21.50M | -$16.00M | -$32.20M | -$9.20M | -$19.80M |
| 业务购买及出售净额 | $100,000.00 | -$3.30M | -$173.90M | -$121.30M | -$800,000.00 |
| 其他投资变动净额 | $1.60M | $5.90M | -$40.50M | -$9.00M | -$12.20M |
| 筹资活动现金流 | -$5.10M | -$55.90M | -$57.30M | $59.20M | -$84.10M |
| 持续经营筹资活动现金流净额 | -$5.10M | -$55.90M | -$57.30M | $59.20M | -$84.10M |
| 债务发行及偿还净额 | $38.20M | $1.60M | $162.80M | $113.10M | -$33.10M |
| 其他筹资费用净额 | -$43.30M | -$57.50M | -$220.10M | -$53.90M | -$51.00M |
| 期末现金余额 | $216.70M | $182.30M | $239.90M | $239.90M | $203.40M |
| 现金净变动 | $34.40M | -$57.60M | -$29.60M | $36.50M | -$46.70M |
| 期初现金余额 | $182.30M | $239.90M | $269.50M | $203.40M | $250.10M |
| 自由现金流 | $37.50M | -$4.30M | $195.60M | $90.60M | $63.80M |
暂无评论——快来第一个聊聊 SGRY。
登录后参与讨论。